Show simple item record

dc.contributor.authorNazato, D. M. [UNIFESP]
dc.contributor.authorAbucham Filho, Júlio Zaki [UNIFESP]
dc.date.accessioned2020-07-20T16:31:12Z
dc.date.available2020-07-20T16:31:12Z
dc.date.issued2018
dc.identifierhttp://dx.doi.org/10.1007/s40618-017-0770-3
dc.identifier.citationJournal Of Endocrinological Investigation. New York, v. 41, n. 4, p. 447-454, 2018.
dc.identifier.issn1720-8386
dc.identifier.urihttps://repositorio.unifesp.br/handle/11600/55778
dc.description.abstractPurpose TSH-secreting pituitary adenomas are among the less prevalent pituitary tumors, corresponding to 0.9-1.5% of all pituitary adenomas in surgical series. Methods A series of 11 patients with TSH-secreting and cosecreting adenomas diagnosed and treated in the last 25 years in a single center is described. Results The mean age at diagnosis was 37 years (range 18-80 yearsen
dc.description.abstractmedian 23 years)en
dc.description.abstractthe ratio of male-to-female patients was similar (6M:5F). Only three patients was the correct diagnosis established shortly after the initial medical evaluation. Other four patients were initially diagnosed with other pituitary adenomas (prolactinoma, acromegaly, and non-secreting pituitary tumor) and another four diagnosed with primary hyperthyroidism. There was a mean diagnostic delay of 6.0 years (range 0.5-25 yearsen
dc.description.abstractmedian 2 years). Nine patients had macroadenomas and two patients had microadenomas. Seven patients underwent pituitary surgery which controlled the disease in only two (one micro- and one noninvasive macroadenoma). The other treatments were directed to the thyroid gland (surgery or I-131 radiotherapy), pituitary radiotherapy, and somatostatin analog. Conclusion In spite of its relatively straightforward diagnosis, which includes clinical/subclinical hyperthyroidism with or without goiter, increased free thyroxine and nonsuppressed TSH levels, and pituitary mass, the diagnosis of TSH-secreting and cosecreting adenomas was frequently unrecognized and thus much delayed. Serum alpha-subunit levels were high in nearly all patients with TSH-secreting adenomas and useful in excluding other conditions in the differential diagnosis. Proper indication and interpretation of simple laboratory tests should be emphasized in medical education to improve diagnostic accuracy.en
dc.format.extent447-454
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofJournal Of Endocrinological Investigation
dc.rightsAcesso restrito
dc.subjectTSH-secreting pituitary adenomaen
dc.subjectThyrotropinomaen
dc.subjectPituitary tumorsen
dc.subjectHyperthyroidismen
dc.subjectCentral hyperthyroidismen
dc.titleDiagnosis and treatment of TSH-secreting adenomas: review of a longtime experience in a reference centeren
dc.typeRevisão
dc.description.affiliationUniv Fed Sao Paulo, Escola Paulista Med, Div Endocrinol & Metab, Neuroendocrine Unit, Rua Botucatu 806, BR-04023062 Sao Paulo, SP, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Escola Paulista Med, Div Endocrinol & Metab, Neuroendocrine Unit, Rua Botucatu 806, BR-04023062 Sao Paulo, SP, Brazil
dc.identifier.doi10.1007/s40618-017-0770-3
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000427608300009
dc.coverageNew York
dc.citation.volumev. 41
dc.citation.issue4


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record